Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $132.59 USD
Change Today -0.79 / -0.59%
Volume 559.9K
WAT On Other Exchanges
Symbol
Exchange
New York
As of 8:04 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

waters corp (WAT) Snapshot

Open
$133.30
Previous Close
$133.38
Day High
$133.30
Day Low
$131.64
52 Week High
06/22/15 - $137.39
52 Week Low
10/15/14 - $93.56
Market Cap
11.0B
Average Volume 10 Days
490.5K
EPS TTM
$5.83
Shares Outstanding
82.7M
EX-Date
--
P/E TM
22.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for WATERS CORP (WAT)

waters corp (WAT) Related Businessweek News

View More BusinessWeek News

waters corp (WAT) Details

Waters Corporation operates as an analytical instrument manufacturer in the United States and internationally. The company's Waters division designs, manufactures, sells, and services high performance liquid chromatography, ultra performance liquid chromatography, and mass spectrometry technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. This segment’s products are used to detect, identify, monitor, and measure the chemical, physical, and biological composition of materials, as well as to purify a range of compounds. Its products are also used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its TA division offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability of fine chemicals, pharmaceuticals, water, polymers, and viscous liquids for uses in various industrial, consumer goods, and healthcare products, as well as for life science research. The company also develops and supplies software-based products that interface with its instruments. Its products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is based in Milford, Massachusetts.

6,200 Employees
Last Reported Date: 02/27/15
Founded in 1958

waters corp (WAT) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $797.3K
Interim Chief Financial Officer and Vice Pres...
Total Annual Compensation: $340.1K
Executive Vice President and President of the...
Total Annual Compensation: $508.0K
Vice President, General Counsel and Secretary
Total Annual Compensation: $400.7K
Vice President of Human Resources and Vice Pr...
Total Annual Compensation: $245.1K
Compensation as of Fiscal Year 2014.

waters corp (WAT) Key Developments

Waters Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 04, 2015; Provides Earnings Guidance for the Third Quarter and Full Year 2015

Waters Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 04, 2015. For the quarter, sales were $494,740,000 compared with $481,801,000 a year ago. On a GAAP basis, earnings per diluted share were $1.27 compared to $1.13 for the second quarter of 2014. On a non-GAAP basis, EPS to $1.32 compared to $1.22 in the second quarter of 2014. Operating income was $130,318,000 against $118,395,000 a year ago. Income from operations before income taxes was $123,772,000 against $112,124,000 a year ago. Net income was $105,667,000 against $96,529,000 a year ago. Adjusted Non-GAAP operating income was $134,834,000 against $127,089,000 a year ago. Adjusted Non-GAAP net income was $109,613,000 against $103,870,000 a year ago. In the second quarter of 2015, free cash flow came in at $96 million after funding $24 million of capital expenditures. For the six months, net sales were $955,144,000 compared with $912,309,000 in the first six months of 2014. On a GAAP basis, EPS were $2.41 compared to $1.95 for the comparable period in 2014. On a non-GAAP basis and including adjustments, EPS were $2.52 in the first six months of 2015 as compared to $2.13 in 2014. Operating income was $250,300,000 against $207,156,000 a year ago. Income from operations before income taxes was $237,119,000 against $194,854,000 a year ago. Net income was $201,718,000 against $166,831,000 a year ago. Adjusted Non-GAAP operating income was $258,562,000 against $226,815,000 a year ago. Adjusted Non-GAAP net income was $201,759,000 against $182,491,000 a year ago. This brings year-to-date 2015 free cash flow to $234 million as compared to $218 million for the first half of 2014. For the third quarter of 2015, the company's guidance anticipates constant currency sales growth to come in at about 7%. Currency translation in the quarter is expected to reduce reported sales growth rate by approximately 7%. This top line performance is expected to result in non-GAAP earnings per fully diluted share within a range of $1.33 to $1.43 in the third quarter. For the full year 2015, the company expects operating tax rate to be around 14%. Full year 2015 non-GAAP earnings per fully diluted share are now expected to be in the range of $5.75 to $5.90.

Waters Corporation Announces Executive Changes

Waters Corporation announced that Christopher J O'Connell has been appointed as its new President, Chief Executive Officer (CEO) and member of its Board of Directors, effective in September 2015. Chris joins Waters from Medtronic plc. Over his 21 years at Medtronic, Chris O'Connell held a variety of leadership positions, most recently as president of the Restorative Therapies Group. He provided overall strategic direction and operational management of the group's five divisions, as well as led the integration of the group's activities within the overall strategy of the corporation. Retiring chief executive officer, Douglas A Berthiaume will continue in his role as chairman of Waters' board of directors.

Waters Corporation, Q2 2015 Earnings Call, Jul 28, 2015

Waters Corporation, Q2 2015 Earnings Call, Jul 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WAT:US $132.59 USD -0.79

WAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $85.26 USD -0.01
Mettler-Toledo International Inc $340.38 USD +2.63
PerkinElmer Inc $51.42 USD +0.67
Sigma-Aldrich Corp $139.67 USD +0.09
WR Grace & Co $101.32 USD -0.17
View Industry Companies
 

Industry Analysis

WAT

Industry Average

Valuation WAT Industry Range
Price/Earnings 24.1x
Price/Sales 5.4x
Price/Book 5.7x
Price/Cash Flow 23.1x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WATERS CORP, please visit www.waters.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.